GABRB2 and schizophrenia: Additionally, genetic and epigenetic analyses have identified glial dysregulation in schizophrenia risk, including variants (e.g., gamma-aminobutyric acid A receptor beta 2—GABRB2) and demonstrated disruption of astrocyte–microglia crosstalk in KO mouse models [203,204].